Geron Corporation (GERN) NASDAQ

Currency In USD

AD

Geron Corporation

Address

919 East Hillsdale Boulevard

Foster City, CA 94404

United States of America (the)

Phone

650 473 7700

Sector

Healthcare

Industry

Biotechnology

Employees

229

First IPO Date

July 31, 1996

Key Executives

NameTitlePayYear Born
Harout SemerjianChief Executive Officer, President & Director526,3551970
Ahmed ElNawawiExecutive Vice President & Chief Commercial Officer307,9341981
Timothy WilliamsExecutive Vice President, Chief Legal Officer & Corporate Secretary485,3171977
Michelle J. RobertsonExecutive Vice President, Chief Financial Officer, Treasurer and Principal Financial & Accounting Officer810,5521967
Joseph Emile EidExecutive Vice President of Research & Development and Chief Medical Officer1M1967
Aron FeingoldVice President of Investor Relations & Corporate Communications0N/A
Shannon OdamExecutive Vice President & Chief People Officer01975
Dawn SchottlandtSenior Vice President of Investor Relations & Corporate Affairs0N/A
Bryan RidgellSenior Vice President of Portfolio & Project Management and Chief of Staff0N/A
Shanthakumar TyavanagimattSenior Vice President & Chief Technical Officer0N/A
AD

Description

Geron Corporation is an advanced-stage biopharmaceutical company dedicated to the creation and market introduction of treatments for myeloid blood cancers. Its primary drug candidate, imetelstat, is a telomerase inhibitor currently undergoing Phase 3 clinical evaluation. This therapy aims to suppress the unchecked proliferation of cancerous stem and progenitor cells characteristic of myeloid hematologic malignancies. Imetelstat is being developed to address low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. Established in 1990, Geron's corporate headquarters are located in Foster City, California.

AD